This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Blood Pressure Assessment in Atrial Fibrillation

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2017 by George S. Stergiou, University of Athens
Sponsor:
Information provided by (Responsible Party):
George S. Stergiou, University of Athens
ClinicalTrials.gov Identifier:
NCT01088269
First received: March 16, 2010
Last updated: September 13, 2017
Last verified: September 2017
  Purpose

This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include:

  • clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device)
  • 24-hour ambulatory blood pressure monitoring
  • determination of various serum markers and cardiac ultrasound.
  • evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG

Condition
Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Evaluation of the Oscillometric Blood Pressure Measurement in Atrial Fibrillation and Relation of Blood Pressure With Serum Biomarkers and Echocardiographic Indexes

Resource links provided by NLM:


Further study details as provided by George S. Stergiou, University of Athens:

Primary Outcome Measures:
  • Blood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF) [ Time Frame: Baseline ]
    1. Evaluation of the oscillometric technique of an electronic device in blood pressure measurement.
    2. Evaluation of the relationship of blood pressure levels with serum markers and ultrasonographic cardiac indexes.
    3. Evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG


Estimated Enrollment: 100
Study Start Date: March 2010
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
AF
Hypertensive patients in AF
Non-AF
Hypertensive Patients

  Eligibility

Ages Eligible for Study:   25 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
SUBJECTS REFERRED TO HYPERTENSION CENTER
Criteria

Inclusion Criteria:

  • Hypertensives adults in atrial fibrillation

Exclusion Criteria:

  • Renal disease (Cr > 2 mg/l).
  • Patients with pacemaker rhythm during the study.
  • Each patient with acute disease (inflammation, surgery), malignancy, collagen diseases, pulmonary fibrosis, renal failure, liver failure, chronic inflammatory diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01088269

Contacts
Contact: George S Stergiou, MD +302107763117 gstergi@med.uoa.gr

Locations
Greece
Hypertension Center, Third Internal Medicine Dpt, University of Athens Recruiting
Athens, Greece
Contact: George S. Stergiou    00302107763117    gstergi@med.uoa.gr   
Contact: George S. Stergiou, Professor    00302017763117    gstergi@med.uoa.gr   
Sub-Investigator: Antonios Th. Destounis, Phd candidate         
Sponsors and Collaborators
University of Athens
Investigators
Study Chair: George S Stergiou, MD Hypertension Center,Third Department of Medicine,University of Athens,Greece
  More Information

Responsible Party: George S. Stergiou, Associate Professor of Medicine and Hypertension, University of Athens
ClinicalTrials.gov Identifier: NCT01088269     History of Changes
Other Study ID Numbers: BPM IN AF
Study First Received: March 16, 2010
Last Updated: September 13, 2017

Keywords provided by George S. Stergiou, University of Athens:
Blood Pressure Measurement
Atrial Fibrillation
Blood pressure measurement in atrial fibrillation
Atrial Fibrillation diagnosis

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on September 20, 2017